معرفی
Douglas Slain is the Department Chair of Pharmacy and Therapeutics and a Professor at the School of Pharmacy, University of Pittsburgh. His expertise lies in infectious diseases, antimicrobial stewardship, and clinical pharmacy, with a focus on optimizing antibiotic use and combating antimicrobial resistance. He leads initiatives to advance education, research, and community engagement within the pharmacy program.
- Educations/Credentials: PharmD degree, Board Certified Pharmacotherapy Specialist (BCPS), Fellow of the College of Chest Physicians (FCCP), Fellow of the American Society of Health-System Pharmacists (FASHP).
- Research Interests: Development of antimicrobial resistance, treatment strategies for Serratia infections, antifungal dosing in obesity, and the impact of clinical pharmacist interventions on antibiotic appropriateness.
His research spans in vitro resistance experiments, clinical cohort studies, and guideline development, including contributions to the 2013 Surgeon Antimicrobial Prophylaxis Guidelines. He has published extensively in journals like Open Forum Infectious Diseases and Journal of Antimicrobial Chemotherapy, with a focus on translational research addressing real-world clinical challenges.
- Awards: FCCP and FASHP fellowships, recognized for leadership in clinical pharmacy and antimicrobial stewardship.
- Grants/Advisees: No explicit grants noted, but his work is supported through institutional and collaborative research programs.
He oversees interdisciplinary teams advancing antimicrobial stewardship initiatives, emphasizing pharmacist-led interventions and evidence-based practices to improve patient outcomes.
